Back to Results
First PageMeta Content
Organic chemistry / Phenols / Morphinans / Drug rehabilitation / Amines / Methadone / Neuropathic pain / Buprenorphine / Levorphanol / Medicine / Chemistry / Pain


        Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical
Add to Reading List

Document Date: 2014-12-22 13:33:41

Open Document

File Size: 255,46 KB

Share Result on Facebook

City

New York / /

Company

Relmada Therapeutics Inc. / /

Country

United States / /

/

Event

FDA Phase / /

IndustryTerm

chemical entities / traded specialty pharmaceutical company developing novel versions / drug products / /

MedicalCondition

pain / painful diabetic neuropathy / injury / disorder / chronic pain / trigeminal neuralgia / inflammation / postherpetic neuralgia / /

MedicalTreatment

pain management / /

Organization

Neuropathy Association / /

Person

Sergio Traversa / Michael Becker / /

/

Position

SVP of Finance / chief executive officer / /

Product

disomer / MepiGel / /

Technology

pharmacokinetics / pharmacodynamics / /

URL

www.relmada.com / /

SocialTag